Terminalia chebula extract acts as a potential NF-κB inhibitor in human lymphoblastic T cells

Phytotherapy Research

Volumn 25, Issue 6, 2011, Pages 927-934

  Das, Nando Dulal ^a   Jung, Kyoung Hwa ^a   Park, Ji Hyun ^a   Mondol, Md Abdul Mojid ^b   Shin, Hee Jae ^b   Lee, Hyi Seung ^b   Park, Kyoung Sun ^a   Choi, Mi Ran ^a   Kim, Kyung Suk ^c   Kim, Moo Sung ^d   Lee, Sang Rin ^d   Chai, Young Gyu ^a  

^a Hanyang University   (South Korea)

^b Korea Research Institute of Ships and Ocean Engineering   (South Korea)

^c Bioengineering Institute   (South Korea)

^d MacroCare Company   (South Korea)

Author keywords

cell based assay; fluorescence resonance energy transfer; Jurkat cells; nuclear factor kappa B; TC extract

Indexed keywords

GALLIC ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TERMINALIA CHEBULA EXTRACT;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANIMALS; GALLIC ACID; HUMANS; JURKAT CELLS; MICE; NF-KAPPA B; PLANT EXTRACTS; T-LYMPHOCYTES; TERMINALIA;

TERMINALIA CHEBULA;

EID: 79957838312     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3398     Document Type: Article

References (42)

1. Allen-Hall L, Arnason JT, Cano P, et al,. 2009. Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB. J Ethnopharmacol 127: 685-693.
2. Aqil F, Khan MS, Owais M, et al,. 2005. Effect of certain bioactive plant extracts on clinical isolates of beta-lactamase producing methicillin resistant Staphylococcus aureus. J Basic Microbiol 45: 106-114. (Pubitemid 40589305)
3. Baik SY, Jung KH, Choi MR, et al,. 2005. Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells. Neurosci Lett 374: 53-57. (Pubitemid 41556547)
4. Basseres DS, Baldwin AS,. 2006. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25: 6817-6830. (Pubitemid 44657854)
5. Bharti AC, Donato N, Singh S, et al,. 2003. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101: 1053-1062. (Pubitemid 36139379)
6. Choi KC, Lee YH, Jung MG, et al,. 2009. Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol Cancer Res 7: 2011-2021.
7. Das ND, Jung KH, Chai YG,. 2010. The role of NF-kappaB and H3K27me3 demethylase, Jmjd3, on the anthrax lethal toxin tolerance of RAW 264.7 cells. PLoS One 5: e9913.
8. Desaki M, Okazaki H, Sunazuka T, et al,. 2004. Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. Antimicrob Agents Chemother 48: 1581-1585. (Pubitemid 38544362)
9. Fabry W, Okemo PO, Ansorg R,. 1998. Antibacterial activity of East African medicinal plants. J Ethnopharmacol 60: 79-84. (Pubitemid 28098343)
10. Faried A, Kurnia D, Faried LS, et al,. 2007. Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol 30: 605-613.
11. Ghosh S, May MJ, Kopp EB,. 1998. Nf-kappa b and rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260. (Pubitemid 28183365)
12. Hartwell JL,. 1982. Plants Used Against Cancer. Quarterman Publications, Inc.: Lawrence, MA, USA.
13. Juang LJ, Sheu SJ, Lin TC,. 2004. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J Sep Sci 27: 718-724.
14. Jung KH, Seo GM, Yoon JW, et al,. 2008. Protein expression pattern of murine macrophages treated with anthrax lethal toxin. Biochim Biophys Acta 1784: 1501-1506.
15. Karin M, Yamamoto Y, Wang QM,. 2004. The IKK NF-kappa B system: A treasure trove for drug development. Nat Rev Drug Discov 3: 17-26. (Pubitemid 38088695)
16. Koga M, Kai H, Egami K, et al,. 2008. Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice. Biochem Biophys Res Commun 365: 279-284. (Pubitemid 350137285)
17. Kordes U, Krappmann D, Heissmeyer V, et al,. 2000. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 14: 399-402. (Pubitemid 30142862)
18. Kucharczak J, Simmons MJ, Fan Y, et al,. 2003. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22: 8961-8982. (Pubitemid 38121698)
19. Kumar A, Takada Y, Boriek AM, et al,. 2004. Nuclear factor-kappaB: Its role in health and disease. J Mol Med 82: 434-448. (Pubitemid 39044283)
20. Lee SH, Ryu SY, Sang U, et al,. 1995. Hydrolyzable tannins and related compound having cytotoxic activity from the fruits of Terminalia chebula. Arch Pharmacol Res 18: 118-120.
21. Li L, Ng TB, Gao W, et al,. 2005. Antioxidant activity of gallic acid from rose flowers in senescence accelerated mice. Life Sci 77: 230-240. (Pubitemid 40603507)
22. Luqman S, Pezzuto JM,. 2010. NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res 24: 949-963.
23. Morais MC, Luqman S, Kondratyuk TP, et al,. 2010. Suppression of TNF-alpha induced NFkappaB activity by gallic acid and its semi-synthetic esters: possible role in cancer chemoprevention. Nat Prod Res 24: 1758-1765.
24. Murase T, Kume N, Hase T, et al,. 1999. Gallates inhibit cytokine induced nuclear translocation of NFκB and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler Thromb Vasc Biol 19: 1412-1420. (Pubitemid 29263010)
25. Nelson G, Paraoan L, Spiller DG, et al,. 2002. Multi-parameter analysis of the kinetics of NF-kappaB signalling and transcription in single living cells. J Cell Sci 115: 1137-1148. (Pubitemid 34272479)
26. Ng TB, He JS, Niu SM, et al,. 2004. A gallic acid derivative and polysaccharides with antioxidative activity from rose (Rosa rugosa) flowers. J Pharm Pharmacol 56: 537-545. (Pubitemid 38455620)
27. Paur I, Austenaa LM, Blomhoff R,. 2008. Extracts of dietary plants are efficient modulators of nuclear factor kappa B. Food Chem Toxicol 46: 1288-1297. (Pubitemid 351258206)
28. Perkins ND,. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62. (Pubitemid 46012014)
29. Pettit GR, Hoard MS, Doubek DL, et al,. 1996. Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae). J Ethnopharmacol 53: 57-63. (Pubitemid 26257077)
30. Pfaffl MW,. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
31. Pierce JW, Schoenleber R, Jesmok G, et al,. 1997. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272: 21096-21103. (Pubitemid 27373968)
32. Place RF, Haspeslagh D, Hubbard AK, et al,. 2001. Cytokine-induced stabilization of newly synthesized I(kappa)B-alpha. Biochem Biophys Res Commun 283: 813-820. (Pubitemid 32924652)
33. Reddy DB, Reddy TC, Jyotsna G, et al,. 2009. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J Ethnopharmacol 124: 506-512.
34. Sabu MC, Kuttan R,. 2002. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 81: 155-160. (Pubitemid 34628497)
35. Saleem A, Husheem M, Harkonen P, et al,. 2002. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol 81: 327-336. (Pubitemid 34786317)
36. Scarlett JL, Sheard PW, Hughes G, et al,. 2000. Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 475: 267-272. (Pubitemid 30408466)
37. Setty AR, Sigal LH,. 2005. Herbal medications commonly used in the practice of rheumatology: Mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum 34: 773-784. (Pubitemid 40732452)
38. Sparmann A, Bar-Sagi D,. 2004. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6: 447-458. (Pubitemid 39469981)
39. Sun SC, Ley SC,. 2008. New insights into NF-kappaB regulation and function. Trends Immunol 29: 469-478.
40. Takada Y, Andreeff M, Aggarwal BB,. 2005. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106: 641-649. (Pubitemid 40981262)
41. Weil R, Israel A,. 2004. T-cell-receptor- and b-cell-receptor-mediated activation of NF-kappaB in lymphocytes. Curr Opin Immunol 16: 374-381. (Pubitemid 38595377)
42. Zhang J, Warren MA, Shoemaker SF, et al,. 2007. NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: Implications for NFkappaB2/p52 and RelB. Endocrinology 148: 268-278. (Pubitemid 46021459)